Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Walsh

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2011
Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)G Young, A D Shapiro, C E Walsh, et al.
Experimental Cell Research|February 2, 1999
Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell deathC Guillouf, T S Wang, J Liu, et al.
Blood|November 14, 1997
Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transferK L Fu, J R Foe, H Joenje, et al.
British Journal of Haematology|January 1, 1992
A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemiaC E Walsh, J M Liu, S M Anderson, et al.
Carcinogenesis|September 2, 1999
A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNAD W Brois, L W McMahon, N I Ramos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2012
Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE)L A Valentino, C E Walsh, M T Reding, et al.
Blood|July 15, 1994
A functionally active retrovirus vector for gene therapy in Fanconi anemia group CC E Walsh, M Grompe, E Vanin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 4, 2016
Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trialsC Negrier, G Young, F Abdul Karim, et al.
Journal of Hematotherapy|April 1, 1995
Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndromeM H Qazilbash, C E Walsh, S M Russell, et al.
Experimental Hematology|October 1, 1992
Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failureJ P Maciejewski, J M Liu, S W Green, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 17, 2011
Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE)G Young, A D Shapiro, C E Walsh, et al.
Experimental Cell Research|February 2, 1999
Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell deathC Guillouf, T S Wang, J Liu, et al.
Blood|November 14, 1997
Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transferK L Fu, J R Foe, H Joenje, et al.
British Journal of Haematology|January 1, 1992
A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anaemiaC E Walsh, J M Liu, S M Anderson, et al.
Carcinogenesis|September 2, 1999
A deficiency in a 230 kDa DNA repair protein in fanconi anemia complementation group A cells is corrected by the FANCA cDNAD W Brois, L W McMahon, N I Ramos, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 22, 2012
Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE)L A Valentino, C E Walsh, M T Reding, et al.
Blood|July 15, 1994
A functionally active retrovirus vector for gene therapy in Fanconi anemia group CC E Walsh, M Grompe, E Vanin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 4, 2016
Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trialsC Negrier, G Young, F Abdul Karim, et al.
Journal of Hematotherapy|April 1, 1995
Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndromeM H Qazilbash, C E Walsh, S M Russell, et al.
Experimental Hematology|October 1, 1992
Expression of stem cell inhibitor (SCI) gene in patients with bone marrow failureJ P Maciejewski, J M Liu, S W Green, et al.
Pageof 5